Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation in Refractory Clostridium Difficile Colitis
NCT02127398Phase 2Recruiting
- Sponsor
- Duke University
- Start
- Apr 2016
- Primary completion
- May 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in Refractory Clostridioides difficile colitis, sponsored by Duke University. Started Apr 2016; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Refractory Clostridioides difficile colitis
Beyond the preview
Go deeper on NCT02127398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127398.